NDC 0173-0887 Trelegy Ellipta
Fluticasone Furoate,Umeclidinium Bromide And Vilanterol Trifenatate Powder Respiratory - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 0173 - Glaxosmithkline Llc
- 0173-0887 - Trelegy Ellipta
Product Packages
NDC Code 0173-0887-10
Package Description: 1 TRAY in 1 CARTON / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER
Price per Unit: $10.52946 per EA
NDC Code 0173-0887-14
Package Description: 1 TRAY in 1 CARTON / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER
Price per Unit: $10.55569 per EA
NDC Code 0173-0887-61
Package Description: 1 TRAY in 1 CARTON / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER
Product Details
What is NDC 0173-0887?
What are the uses for Trelegy Ellipta?
What are Trelegy Ellipta Active Ingredients?
Which are Trelegy Ellipta UNII Codes?
The UNII codes for the active ingredients in this product are:
- FLUTICASONE FUROATE (UNII: JS86977WNV)
- FLUTICASONE (UNII: CUT2W21N7U) (Active Moiety)
- UMECLIDINIUM BROMIDE (UNII: 7AN603V4JV)
- UMECLIDINIUM (UNII: GE2T1418SV) (Active Moiety)
- VILANTEROL TRIFENATATE (UNII: 40AHO2C6DG)
- VILANTEROL (UNII: 028LZY775B) (Active Moiety)
Which are Trelegy Ellipta Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
What is the NDC to RxNorm Crosswalk for Trelegy Ellipta?
- RxCUI: 1945039 - fluticasone furoate 100 MCG/ACTUAT / umeclidinium 62.5 MCG/ACTUAT / vilanterol 25 MCG/ACTUAT Dry Powder Inhaler, 14 Blisters
- RxCUI: 1945039 - 14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler
- RxCUI: 1945039 - fluticasone furoate 100 MCG/ACTUAT / umeclidinium (as umeclidinium Br) 62.5 MCG/ACTUAT / vilanterol (as vilanterol trifenatate) 25 MCG/ACTUAT Dry Powder Inhaler, 14 ACTUAT
- RxCUI: 1945044 - TRELEGY ELLIPTA 100 MCG / 62.5 MCG / 25 MCG Dry Powder Inhaler, 14 Blisters
- RxCUI: 1945044 - 14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy]
Which are the Pharmacologic Classes for Trelegy Ellipta?
- Adrenergic beta2-Agonists - [MoA] (Mechanism of Action)
- Anticholinergic - [EPC] (Established Pharmacologic Class)
- Cholinergic Antagonists - [MoA] (Mechanism of Action)
- Corticosteroid Hormone Receptor Agonists - [MoA] (Mechanism of Action)
- Corticosteroid - [EPC] (Established Pharmacologic Class)
- beta2-Adrenergic Agonist - [EPC] (Established Pharmacologic Class)
* Please review the disclaimer below.
Patient Education
Fluticasone, Umeclidinium, and Vilanterol Oral Inhalation
The combination of fluticasone, umeclidinium, and vilanterol is used to control wheezing, shortness of breath, coughing, and chest tightness caused by chronic obstructive pulmonary (COPD; a group of diseases that affect the lungs and airways, that includes chronic bronchitis and emphysema). It is also used in adults to control wheezing, shortness of breath, coughing, and chest tightness caused by asthma. Fluticasone is in a class of medications called steroids. Umeclidinium is in a class of medication called anticholinergics. Vilanterol is in a class of medications called long-acting beta-agonists (LABAs). The combination of fluticasone, umeclidinium, and vilanterol works by relaxing and opening air passages in the lungs, making it easier to breathe.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".